Skip to content

Drug interactions

Lapatinib + Pomalidomide

Severity: Minor

Lapatinib and Pomalidomide: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lapatinib inhibits P-glycoprotein, and pomalidomide is a P-gp substrate, so its exposure might increase. The expected effect is modest and clinical consequences are uncertain.

What this interaction means in plain words

Lapatinib and Pomalidomide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Lapatinib belongs to Oncology; Pomalidomide belongs to Miscellaneous.

Evidence level: Low

Why it happens

P-glycoprotein inhibition by lapatinib may reduce pomalidomide efflux.

What to do

No dose change is generally needed; monitor for pomalidomide adverse effects such as neutropenia.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lapatinib and Pomalidomide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lapatinib with Pomalidomide?

MediHelp rates the interaction as minor. Lapatinib and Pomalidomide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Lapatinib inhibits P-glycoprotein, and pomalidomide is a P-gp substrate, so its exposure might increase. The expected effect is modest and clinical consequences are uncertain.

How serious is the interaction between Lapatinib and Pomalidomide?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is generally needed; monitor for pomalidomide adverse effects such as neutropenia.

What other medicines interact with Lapatinib?

MediHelp also lists interactions of Lapatinib with, for example, Dofetilide, Ibutilide, Pimozide. The full list is on the Lapatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in